Ingelise Saunders
Chairman of the Board
Board of Directors
Acesion Pharma
Denmark
Biography
Ingelise Saunders has more than 35 years of experience in the biotech and pharmaceutical industry. Until September 2013 she was CEO of the Swedish life science investment company SLS Invest AB. Prior to that she was CEO in three privately owned Danish Biotech companies, among these Action Pharma A/S, which was sold to Abbott in 2012. Prior experience includes 16 years at Novo Nordisk A/S in a number of Executive Management positions both in Denmark and in the UK. Apart from being Chairman of the Board of Acesion Pharma Ingelise Saunders is today a Director of the Board of Leo Pharma A/S, Chairman of the Board of MinervaX ApS and CEO of Meta-IQ.
Research Interest
Biotech and pharmaceutical
